InvestorsHub Logo
Followers 6
Posts 703
Boards Moderated 0
Alias Born 09/23/2006

Re: None

Tuesday, 07/26/2016 8:41:23 AM

Tuesday, July 26, 2016 8:41:23 AM

Post# of 303
2nd Quarter Earnings
Looks pretty good, Reuters is reporting revenue of $63.1 million, $2 million above estimates, just like I predicted. Adjusted revenue of 4 cents/share is 1 cent better than estimates.

* Neogenomics reports 159% revenue growth to $63.1 million and strong gains in profitability in the second quarter of 2016

* Q2 adjusted earnings per share $0.04

* Q2 loss per share $0.07

* Q2 revenue $63.1 million versus i/b/e/s view $61.1 million

* Q2 earnings per share view $0.03 -- Thomson Reuters I/B/E/S

Time will tell how the street views the results. Looking forward to the CC.

GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NEO News